| Ytd | 64.26% | |
| 1y | 67.75% |
| Open | 13.26 | Prev Close | 13.32 | Low | 12.97 | High | 13.56 | Mkt Cap | 2.93B |
| Vol | 4.04M | Avg Vol | 2.66M | EPS | 1.27 | P/E | 10.57 | Forward P/E | 14.94 |
| Beta | 1.93 | Short Ratio | 2.13 | Inst. Own | 93.54% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 10.16 | 200-d Avg | 8.30 | 1yr Est | 13.35 |
Aveanna Healthcare Holdings demonstrates strong revenue and earnings growth, with a focus on private
An aging population and growing telehealth and AI adoption support the Zacks Medical - Outpatient an
Barclays analyst Andrew Mok maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight an
Aveanna (AVAH) is at a 52-week high, but can investors hope for more gains in the future? We take a
Does Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let
ATLANTA, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVA
Aveanna Healthcare (AVAH) shares have started gaining and might continue moving higher in the near t
Prefer to listen? Hear this as a ~5-minute audio briefing on The GuruFocus Brief.Stock NewsTarget pu
ATLANTA, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVA
Truist Securities analyst David Macdonald maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a
RBC Capital analyst Ben Hendrix maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Outperfor
Gainers Werewolf Therapeutics (NASDAQ:HOWL) shares moved upwards by 74.6% to $0.75 during Friday
US stock futures rise, Dow up 150 points. Flowers Foods (NYSE:FLO) plunges on poor earnings & lo
Ross Stores beats estimates with Q2 financial results, shares jump 9.1%. Other gainers include RFAI,
ATLANTA, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leadin
Gainers Werewolf Therapeutics (NASDAQ:HOWL) stock moved upwards by 77.1% to $0.76 during Thursday&#
ATLANTA, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leadin
UBS analyst A.J. Rice maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Neutral and raises
Raymond James analyst John Ransom maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Strong
Aveanna raises its 2026 outlook and long-term growth targets as reimbursement gains and preferred pa
BMO Capital analyst Sean Dodge maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Outperform
Aveanna Healthcare Holdings Inc. (AVAH) Q2 2026 Earnings Call Transcript
Aveanna Healthcare Holdings delivered strong Q2 2026 results, beating earnings and revenue estimates
Aveanna Healthcare NASDAQ: AVAH reported higher second-quarter revenue and adjusted EBITDA, supporte
Although the revenue and EPS for Aveanna (AVAH) give a sense of how its business performed in the qu
Nasdaq Composite gained 200 points on Thursday, while Accelerant Holdings (NYSE: ARX) rose 44.2% af
Aveanna Healthcare (AVAH) came out with quarterly earnings of $0.22 per share, beating the Zacks Con
Aveanna Healthcare Hldgs (NASDAQ:AVAH) reported quarterly earnings of $0.22 per share which beat the
Second Quarter Revenue was $670.5 million, a 13.7% increase over the prior year period Second Quarte
AVAH's Q2 revenues are expected to rise 9.8%, but lower PDS margins and higher costs may weigh on ea
Investors need to pay close attention to AVAH stock based on the movements in the options market lat
Besides Wall Street's top-and-bottom-line estimates for Aveanna (AVAH), review projections for some
Truist Securities analyst David Macdonald maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a
Barclays analyst Andrew Mok maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight an
RBC Capital analyst Ben Hendrix upgrades Aveanna Healthcare Hldgs (NASDAQ:AVAH) from Sector Perfo
Aveanna Healthcare ($AVAH) boosts 2026 guidance, projecting up to $2.65B in revenue and $342M in adj
Aveanna Healthcare Hldgs (NASDAQ:AVAH) raises FY2026 sales outlook from $2.560 billion-$2.580 billio
Truist Securities analyst David Macdonald maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a
Barclays analyst Andrew Mok maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Overweight an
Stephens & Co. analyst Scott Fidel upgrades Aveanna Healthcare Hldgs (NASDAQ:AVAH) from Equa
RBC Capital analyst Ben Hendrix maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Sector Pe
Full Year 2026 GuidanceThe following is our guidance reflecting our increased expectations for reven
Aveanna Healthcare Hldgs (NASDAQ:AVAH) reported quarterly earnings of $0.18 per share which beat the
https://www.cms.gov/newsroom/press-releases/cms-announces-aggressive-nationwide-crackdown-fraud-six-